Wellell Inc. (TPE:4106)
22.55
+0.10 (0.45%)
May 14, 2025, 12:37 PM CST
Wellell Revenue
In the year 2024, Wellell had annual revenue of 2.39B TWD, down -9.84%. Wellell had revenue of 613.67M in the quarter ending December 31, 2024, a decrease of -9.61%.
Revenue
2.39B
Revenue Growth
-9.84%
P/S Ratio
0.95
Revenue / Employee
n/a
Employees
n/a
Market Cap
2.27B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 2.39B | -260.47M | -9.84% |
Dec 31, 2023 | 2.65B | -16.60M | -0.62% |
Dec 31, 2022 | 2.66B | 289.67M | 12.20% |
Dec 31, 2021 | 2.37B | 370.03M | 18.46% |
Dec 31, 2020 | 2.00B | -32.21M | -1.58% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
PharmaEssentia | 11.34B |
Caliway Biopharmaceuticals | 40.47M |
Bora Pharmaceuticals Co., LTD. | 19.25B |
Lotus Pharmaceutical | 18.58B |
Polaris Group | 107.00M |
Oneness Biotech | 117.93M |
Pegavision | 6.69B |
Lumosa Therapeutics | 43.59M |